Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation

大麻二酚减少脑神经炎症的评价

基本信息

  • 批准号:
    10413981
  • 负责人:
  • 金额:
    $ 75.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-01 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Millions of individuals in the United States suffer from chronic pain and co-morbid depression, conditions that are debilitating and complex to manage. A reason for the scarcity of safe and efficacious therapies for these conditions is our limited knowledge of viable targets. Preclinical models of pain have shown that microglia and astrocytes play a key role in the establishment and/or maintenance of pain and depressive behaviors. Additionally, patients with chronic low back pain (cLBP) demonstrate “pain-related” and “depression-related” elevated levels of the glial marker 18kDa translocator protein (TSPO), suggesting that pain and depressive symptoms may be mediated / maintained by neuroinflammatory mechanisms In this proposal, we will study whether cannabidiol (CBD), the primary centrally and peripherally active non-intoxicating compound in the cannabis plant, exerts anti-neuroinflammatory effects in patients with cLBP with mild-to-moderate depression. In animals, CBD induces analgesic and antidepressant effects, via a complex pharmacology that includes the stimulation of cannabinoid receptors and the inhibition of pro- inflammatory pathways in glial cells. These preclinical studies, and our observations linking neuroinflammation to pain and comorbid depressive symptoms in cLBP, indicate that CBD may reduce both pain- and depression- related neuroinflammation in cLBP patients. In addition to exerting possible anti-neuroinflammatory effects, studies in psychiatric patients suggest that CBD might normalize striatal hypofunction, an alteration that our group has also recently linked to depression in cLBP patients using functional magnetic resonance imaging (fMRI). Because of its purported effects as striatal physiology, we thus hypothesize that a secondary mechanism of action of CBD may be to reduce striatal dysfunction. We will conduct a randomized, double-blind, 2-arm mechanistic trial to assess the effects of CBD (n = 40) and placebo (n = 40) in patients with cLBP with mild-to-moderate depression, using integrated positron emission tomography / magnetic resonance imaging (PET/MRI) scans. The use of integrated PET/MRI will allow us to simultaneously evaluate neuroinflammation (using [11C]PBR28, a second-generation radioligand for TSPO) and striatal function (using the Monetary Incentive Delay task, a validated fMRI task that probes behavioral and neural responses to rewards and losses). In our mechanistic trial, we will use EPIDIOLEX®, an FDA-approved product that contains a known and constant dose of purified CBD. We already hold an active IND to test the effects of EPIDIOLEX® in cLBP with [11C]PBR28 PET/MRI, and preliminary data support our hypotheses. By studying the neural and neuroimmune responses to CBD, this study will advance our knowledge about the mechanisms of action of this drug, and help us understand which conditions might benefit the most from its use. More broadly, our study will test whether modulating neuroinflammation is feasible and a promising therapeutic approach for pain and depression.
在美国,数百万人患有慢性疼痛和共病抑郁症,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jodi Gilman其他文献

Jodi Gilman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jodi Gilman', 18)}}的其他基金

Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation
大麻二酚减少脑神经炎症的评价
  • 批准号:
    10185880
  • 财政年份:
    2021
  • 资助金额:
    $ 75.33万
  • 项目类别:
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function
使用神经影像标记物了解大麻对大脑结构和功能的危险因素和后果
  • 批准号:
    10681316
  • 财政年份:
    2021
  • 资助金额:
    $ 75.33万
  • 项目类别:
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function
使用神经影像标记物了解大麻对大脑结构和功能的危险因素和后果
  • 批准号:
    10468167
  • 财政年份:
    2021
  • 资助金额:
    $ 75.33万
  • 项目类别:
Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation
大麻二酚减少脑神经炎症的评价
  • 批准号:
    10605299
  • 财政年份:
    2021
  • 资助金额:
    $ 75.33万
  • 项目类别:
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function
使用神经影像标记物了解大麻对大脑结构和功能的危险因素和后果
  • 批准号:
    10301282
  • 财政年份:
    2021
  • 资助金额:
    $ 75.33万
  • 项目类别:
Medical Marijuana, Neurocognition, and Subsequent Substance Use
医用大麻、神经认知和后续药物使用
  • 批准号:
    9309847
  • 财政年份:
    2017
  • 资助金额:
    $ 75.33万
  • 项目类别:
Neurobehavioral Characterization of Social Influence in Drug Addiction
吸毒成瘾的社会影响的神经行为特征
  • 批准号:
    8650806
  • 财政年份:
    2013
  • 资助金额:
    $ 75.33万
  • 项目类别:
Neurobehavioral Characterization of Social Influence in Drug Addiction
吸毒成瘾的社会影响的神经行为特征
  • 批准号:
    9039573
  • 财政年份:
    2013
  • 资助金额:
    $ 75.33万
  • 项目类别:
Neurobehavioral Characterization of Social Influence in Drug Addiction
吸毒成瘾的社会影响的神经行为特征
  • 批准号:
    8827747
  • 财政年份:
    2013
  • 资助金额:
    $ 75.33万
  • 项目类别:
Neurobehavioral Characterization of Social Influence in Drug Addiction
吸毒成瘾的社会影响的神经行为特征
  • 批准号:
    9258413
  • 财政年份:
    2013
  • 资助金额:
    $ 75.33万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 75.33万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 75.33万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了